TABLE 5.
Sequential mediation analyses: effects of social deprivation on preemptive kidney transplantation
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Natural direct effect | 0.69 | [0.61-0.78] | 0.70 | [0.62-0.80] | 0.70 | [0.62-0.80] | 0.71 | [0.62-0.81] | 0.72 | [0.63-0.82] |
| Natural indirect effect | 0.92 | [0.89-0.95] | 0.90 | [0.87-0.94] | 0.90 | [0.87-0.94] | 0.90 | [0.86-0.93] | 0.89 | [0.85-0.92] |
| Total effect | 0.64 | [0.56-0.73] | 0.64 | [0.56-0.73] | 0.64 | [0.55-0.73] | 0.64 | [0.55-0.73] | 0.64 | [0.55-0.73] |
The analyses were adjusted for confounders: age, sex, diabetes, and underlying nephropathy.
Model 1: mediation analysis with a single mediator—living-donor transplantation.
Model 2: mediation analysis with 2 mediators—living-donor transplantation and positive CMV serology.
Model 3: mediation analysis with 3 mediators—living-donor transplantation, positive CMV serology, and HLA immunization.
Model 4: mediation analysis with 4 mediators—living-donor transplantation, positive CMV serology, HLA immunization, and positive hepatitis C serology.
Model 5: complete mediation analysis with the 5 mediators described in the DAG—living-donor transplantation, positive CMV serology, HLA immunization, positive hepatitis C serology, and blood group B.
CI, confidence interval; CMV, cytomegalovirus; DAG, directed acyclic graph; OR, odds ratio.